Elixia MA is a clinical research site located in Springfield, Massachusetts, United States 01103.
Crixeo Health Trust Score: 63/100 (FAIR). This profile has not yet been claimed by the site owner.
Elixia MA has participated in 3 clinical trials with 3 currently active.
Therapeutic areas: Treatment Resistant Depression, Bipolar Disorder, Early Alzheimers Disease.
Sponsors: atai Therapeutics, Inc., Eli Lilly and Company, Annovis Bio Inc..
Trust Score: 63/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Elixia MA has a Crixeo Trust Score of 63/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Elixia MA has 3 clinical trials on record, with 3 currently active. Their work covers Treatment Resistant Depression, Bipolar Disorder, Early Alzheimers Disease.
Elixia MA has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.